Scientists have reported an important breakthrough in the control of oral anticoagulation, the blood thinning treatment currently given to approximately one million patients in the UK for thrombotic disorders.
20 October, 2010
With access, cost and quality concerns plaguing pharmaceutical delivery systems both in the US as well as globally, the Next Generation Pharmaceutical Drug Discovery committee has been formed to confront, assess and deliver new strategies to secure the future of the industry. Meeting in Miami, Florida, the committee will discuss the state-of-play for personalized medicine, R&D challenges, translational medicine, imaging techniques and novel biomarkers – all connected by the pulse of the sector: the call for open innovation.
08 October, 2010